Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

320.00p
   
  • Change Today:
      16.50p
  • 52 Week High: 445.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 159,159
  • Market Cap: £339.20m
  • RiskGrade: 125
  • Beta: 0.01

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

By Frank Prenesti

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
The Oxford-based gene and cell therapy group said it expected to record about £30m in revenue from the contract in the current financial year.

Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 320.00p
Change Today 16.50p
% Change 5.44 %
52 Week High 445.00p
52 Week Low 232.50p
Volume 159,159
Shares Issued 106.00m
Market Cap £339.20m
Beta 0.01
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.79% below the market average30.79% below the market average30.79% below the market average30.79% below the market average30.79% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Price Trend
44.7% below the market average44.7% below the market average44.7% below the market average44.7% below the market average44.7% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Income Not Available
Growth
1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
16:26 1 @ 321.00p
16:17 170 @ 320.50p
16:17 2 @ 322.00p
16:17 184 @ 321.00p
16:13 29 @ 321.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page